Overview

Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

Status:
Terminated
Trial end date:
2009-01-09
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the effectiveness of preladenant in the prevention (Part 1) or treatment (Part 2) of antipsychotic induced akathisia in participants with acute psychosis using the Barnes Akathisia Scale.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Antipsychotic Agents
Cholinergic Antagonists
Haloperidol
Haloperidol decanoate
Propranolol